Thread by @RajlabN

Tracking #SARSCoV2 #Lineages - Globally

Top lineages -#20DayTrends (#G20):

XBB.1.5 (16.5%)⬇️
XBB.1.16 (10.5%)⬆️
XBB.1.9.1 (7.3%)
FL.4 (4%)
EG.1 (3.6%)
XBB.1.16.1 (3.4%)
XBB.1.9.2 (3.2%)
XBB.2.3.2 (2.6%)
FL.2 (2.5%)
FU.1 (2.1%)

public.tableau.com/app/profile/ra…
Updated 6/4/23

Granular details #Global #20DayTrends

This analysis includes all designated #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 05/15/2023 (6,574 sequences)

In Silico Immune escape and ACE2 receptor binding scores (relative to BA.2)*

Data is intended to prioritize select lineages to generate rapid laboratory experiments to gauge immune escape and ACE2 binding affinity.

[Credits in the legend] *Only Spike RBD mutations considered

Thanks to all the countries that are still supporting #SARSCoV2 testing and rapidly submitting sequences to public databases like @GISAID

#China and #Canada have submitted more sequences than #USA with sample collection dates in the last 20 days!

#SARSCoV2 #Variant Landscape - #China #20DayTrends

#SARSCoV2 #Variant Landscape - #Canada #20DayTrends

#SARSCoV2 #Variant Landscape - #Australia #20DayTrends